| |
| Device | NOVOCURE LTD'S NOVOTTF-100A TREATMENT KIT |
| Generic Name | Stimulator, low electric field, tumor treatment |
| Applicant | Novocure, GmbH Neuhofstrasse 21 Baar 6340 |
| PMA Number | P100034 |
| Date Received | 08/16/2010 |
| Decision Date | 04/08/2011 |
| Product Code |
NZK |
| Docket Number | 11M-0295 |
| Notice Date | 05/06/2011 |
| Advisory Committee |
Neurology |
| Clinical Trials | NCT00379470
|
| Expedited Review Granted? | Yes |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement APPROVAL FOR THE NOVOTTF-100A SYSTEM. THE DEVICE IS INDICATED FOR TREATMENT OF ADULT PATIENTS (22 YEARS OF AGE OR OLDER) WITH HISTOLOGICALLY- CONFIRMED GLIOBLASTOMA MULTIFORME, FOLLOWING HISTOLOGICALLY- OR RADIOLOGICALLY- CONFIRMED RECURRENCE IN THE SUPRATENTORIAL REGION OF THE BRAIN AFTER RECEIVING CHEMOTHERAPY. THE DEVICE IS INTENDED TO BE USED AS A MONOTHERAPY, AND IS INTENDED AS AN ALTERNATIVE TO STANDARD MEDICAL THERAPY FOR GBM AFTER SURGICAL AND RADIATION OPTIONS HAVE BEEN EXHAUSTED. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling
|
| Post-Approval Study | Show Report Schedule and Study Progress |
| Supplements: |
S001 S003 S014 S017 S025 S026 S027 S028 S029 S036 S037 S038 S039 S018 S019 S020 S021 S032 S043 S041 S044 S002 S011 S012 S015 S010 S007 S013 S008 S004 S005 S022 S023 S006 S042 S009 S030 S031 S040 S034 S035 S033 S016 |